1. Home
  2. DCI vs BIO Comparison

DCI vs BIO Comparison

Compare DCI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Donaldson Company Inc.

DCI

Donaldson Company Inc.

HOLD

Current Price

$89.30

Market Cap

11.7B

Sector

Industrials

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$306.68

Market Cap

7.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCI
BIO
Founded
1915
1952
Country
United States
United States
Employees
N/A
7450
Industry
Pollution Control Equipment
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.7B
7.1B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
DCI
BIO
Price
$89.30
$306.68
Analyst Decision
Buy
Buy
Analyst Count
5
4
Target Price
$99.00
$339.75
AVG Volume (30 Days)
480.3K
262.7K
Earning Date
06-02-2026
04-30-2026
Dividend Yield
1.35%
N/A
EPS Growth
N/A
N/A
EPS
1.75
N/A
Revenue
$2,844,900,000.00
N/A
Revenue This Year
$4.58
$2.74
Revenue Next Year
$5.18
$3.20
P/E Ratio
$50.83
$9.72
Revenue Growth
4.05
N/A
52 Week Low
$63.71
$211.43
52 Week High
$112.84
$343.12

Technical Indicators

Market Signals
Indicator
DCI
BIO
Relative Strength Index (RSI) 50.46 70.04
Support Level $88.50 $293.88
Resistance Level $94.26 $311.09
Average True Range (ATR) 1.81 7.49
MACD 0.66 3.03
Stochastic Oscillator 75.74 83.17

Price Performance

Historical Comparison
DCI
BIO

About DCI Donaldson Company Inc.

Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.7 billion in revenue in its fiscal 2025.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: